Price$13.22-0.17 (-1.27%)
02:45 PM06:30 PM
News · 26 weeks36-73%
2025-10-262026-04-19
Mix2290d
- Insider11(50%)
- SEC Filings5(23%)
- Earnings3(14%)
- Other2(9%)
- Leadership1(5%)
Latest news
25 items- PRShoulder Innovations to Report First Quarter 2026 Financial Results on May 13, 2026GRAND RAPIDS, Mich., April 22, 2026 /PRNewswire/ -- Shoulder Innovations, Inc. ("Shoulder Innovations") (NYSE:SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced it will release financial results for the first quarter of 2026 after market close on Wednesday, May 13, 2026. Management will host a conference call to discuss financial results beginning at 4:30 p.m. ET / 1:30 p.m. PT on May 13, 2026. Those interested in listening to the conference call may do so by dialing (877) 407-8216 for domesti
- INSIDERSEC Form 4 filed by Ahearn Matthew Fraser4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)
- SECShoulder Innovations Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement8-K - SHOULDER INNOVATIONS, INC. (0001699350) (Filer)
- INSIDERChief Financial Officer Points Jeffrey S. exercised 13,264 shares at a strike of $2.48 and bought $30,000 worth of shares (2,000 units at $15.00), increasing direct ownership by 27% to 70,785 units (SEC Form 4)4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)
- INSIDERDirector Buckman Paul exercised 45,606 shares at a strike of $2.26 and covered exercise/tax liability with 7,006 shares, increasing direct ownership by 192% to 58,704 units (SEC Form 4)4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)
- INSIDERDirector Buchholz Richard bought $14,840 worth of shares (1,000 units at $14.84), increasing direct ownership by 8% to 13,666 units (SEC Form 4)4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)
- INSIDERCEO & Executive Chairman Ball Robert Joseph bought $33,392 worth of shares (2,200 units at $15.18), increasing direct ownership by 0.80% to 278,866 units (SEC Form 4)4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)
- SECSEC Form S-8 filed by Shoulder Innovations Inc.S-8 - SHOULDER INNOVATIONS, INC. (0001699350) (Filer)
- SECSEC Form 10-K filed by Shoulder Innovations Inc.10-K - SHOULDER INNOVATIONS, INC. (0001699350) (Filer)
- SECShoulder Innovations Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Leadership Update, Financial Statements and Exhibits8-K - SHOULDER INNOVATIONS, INC. (0001699350) (Filer)
- PRShoulder Innovations Reports Fourth Quarter and Full Year 2025 Financial ResultsFourth Quarter Net Revenue Growth Accelerates to 65% Year-Over-YearGRAND RAPIDS, Mich., March 10, 2026 /PRNewswire/ -- Shoulder Innovations, Inc. (Shoulder Innovations, or the company) (NYSE:SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today reported financial results for the fourth quarter and full year ended December 31, 2025. Financial HighlightsGenerated net revenue of $14.4 million in the fourth quarter, a 65% increase over the prior year quarterGenerated net revenue of $47.3 million for the full y
- INSIDERSEC Form 3 filed by new insider Hykes Andrew3 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)
- SECShoulder Innovations Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits8-K - SHOULDER INNOVATIONS, INC. (0001699350) (Filer)
- PRShoulder Innovations Appoints MedTech Veteran Drew Hykes to Board of DirectorsGRAND RAPIDS, Mich., March 2, 2026 /PRNewswire/ -- Shoulder Innovations, Inc. ("Shoulder Innovations") (NYSE:SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced the appointment of Drew Hykes to the company's Board of Directors ("Board") and as a member of the Compensation Committee, effective February 26, 2026. Concurrent with Mr. Hykes's appointment, Geoff Pardo will resign as an Independent Director from the Board. "Drew is a proven healthcare leader, and we are thrilled to welcome him to S
- PRShoulder Innovations to Participate in the Canaccord Genuity 2026 Musculoskeletal ConferenceGRAND RAPIDS, Mich., Feb. 18, 2026 /PRNewswire/ -- Shoulder Innovations, Inc. ("Shoulder Innovations") (NYSE:SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced that members of management will present at the Canaccord Genuity 2026 Musculoskeletal Conference. The presentation will take place at 2:00 p.m. CT / 12:00 p.m. PT on Tuesday, March 3, 2026. A live and archived version of the presentation will be available on the "Investor Relations" section of the Shoulder Innovations website at https
- PRShoulder Innovations to Report Fourth Quarter and Full Year 2025 Financial Results on March 10, 2026GRAND RAPIDS, Mich., Feb. 12, 2026 /PRNewswire/ -- Shoulder Innovations, Inc. ("Shoulder Innovations") (NYSE:SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced it will release financial results for the fourth quarter and full year of 2025 after market close on Tuesday, March 10, 2026. Management will host a conference call to discuss financial results beginning at 4:30 p.m. ET / 1:30 p.m. PT on March 10, 2026. Those interested in listening to the conference call may do so by dialing (877) 40
- INSIDERCEO & Executive Chairman Ball Robert Joseph exercised 12,062 shares at a strike of $2.42, increasing direct ownership by 5% to 276,666 units (SEC Form 4)4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)
- INSIDERSEC Form 4 filed by Chief Financial Officer Points Jeffrey S.4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)
- INSIDERSEC Form 4 filed by Officer Blue David Lawrence4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)
- INSIDERSEC Form 4 filed by CEO & Executive Chairman Ball Robert Joseph4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)
- INSIDERSEC Form 4 filed by Chief Operating Officer Ahearn Matthew Fraser4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)
- PRShoulder Innovations to Participate in the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools ConferenceGRAND RAPIDS, Mich., Feb. 3, 2026 /PRNewswire/ -- Shoulder Innovations, Inc. (Shoulder Innovations, or the Company) (NYSE:SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced that members of management will participate in the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference in Snowbird, UT on Tuesday, February 10, 2026 and Wednesday, February 11, 2026. About Shoulder InnovationsShoulder Innovations is a commercial-stage medical technology company exclusivel
- PRImpulse Dynamics® Announces New Chief Financial OfficerMARLTON, N.J., Jan. 13, 2026 (GLOBE NEWSWIRE) -- Impulse Dynamics®, a global medical device company committed to improving the lives of people with heart failure (HF), announced today the appointment of Richard J. Buchholz as its new Chief Financial Officer (CFO), effective March 2, 2026. "Rick is an accomplished executive with a proven track record in the medical device industry," said Jason Spees, Chief Executive Officer at Impulse Dynamics®. "I am thrilled to welcome Rick to the Impulse Dynamics® team at a time when we are poised for our next phase of growth as we continue to advance our mission of improving patients' lives." Buchholz most recently served as the CFO for Inspire Medi
- INSIDERChief Financial Officer Points Jeffrey S. was granted 1,076 shares, increasing direct ownership by 2% to 55,521 units (SEC Form 4)4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)
- INSIDEROfficer Blue David Lawrence was granted 1,041 shares, increasing direct ownership by 0.75% to 139,372 units (SEC Form 4)4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)